Inhibition of microRNA‑221‑5p induces osteogenic differentiation by directly targeting smad3 in myeloma bone disease mesenchymal stem cells-Reference-Cited by-同舟云学术

Inhibition of microRNA‑221‑5p induces osteogenic differentiation by directly targeting smad3 in myeloma bone disease mesenchymal stem cells

Published:2019-10-17 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Fan Fang‑Yi¹,Deng Rui²,Lai Si‑Han²,Wen Qin¹,Zeng Yunjing¹,Gao Lei¹,Liu Yao¹,Kong Peiyan¹,Zhong Jiangfan¹,Su Yi²,Zhang Xi¹

Affiliation:

1. Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, Sichuan 400037, P.R. China

2. Department of Hematology and Hematopoetic Stem Cell Transplantation Centre, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axis;Journal of Bone Oncology;2023-12

2. Transforming growth factor-beta superfamily regulates mesenchymal stem cell osteogenic differentiation: A microRNA linking;Acta Histochemica;2023-12

3. Unveiling Mesenchymal Stem Cells’ Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications;Cells;2023-10-31

4. Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model;Scientific Reports;2023-10-28

5. Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathways;Pathology - Research and Practice;2023-08